VN1R36P

Across TCGA pan-cancer cohorts, VN1R36P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated VN1R36P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher VN1R36P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated VN1R36P expression acts as an unfavorable survival marker.

BLCA and ACC are the cancer types where VN1R36P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	IV	0.109	0.480	.002	36	view →
ACC	DFS	Tertile	All	0.195	0.748	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

VN1R36P–BLCA (DFS)

Open the BLCA breakdown →